Researchers have uncovered a clue to why immune checkpoint inhibitors-cancer therapies that release the immune "brakes" exploited by tumors to evade attack-show limited efficacy in some brain tumors.

A KAIST research team found that B cell and antibody responses initiated in tumor-draining lymph nodes, rather than T cells alone, are critical to the antitumor effects of anti-CTLA-4 therapy, opening ...

A cancer cell begins to die, and for the first time, a researcher can watch the exact moment it happens. New fluorescent dyes described in two peer-reviewed studies published in spring 2026 are giving ...

A class of ultrasmall fluorescent core-shell silica nanoparticles developed at Cornell is showing an unexpected ability to rally the immune system against melanoma and dramatically improve the ...

South Korean researchers have identified why immune checkpoint inhibitors fail to work against brain tumors such as ...

Stem cells found in the lining of the mouth could help make the most aggressive form of brain cancer easier to treat, according to new research from the University of Reading. The stem cells release a ...

Scientists in Canada have uncovered a surprising weakness in glioblastoma, one of the deadliest brain cancers. They found that certain brain cells—once believed to only support healthy nerves—can ...

Scientists at EPFL have developed CenSpark, a fluorescent probe that makes centrioles and cilia visible inside living cells, helping researchers study cell division, development, and immunity like ...

Gliomas are cancers that originate directly in the brain, instead of spreading to the brain from other parts of the body. These cancers cannot be cured with conventional cancer treatments, as they ...